Skip to main content
. 2019 Apr;10(2):300–306. doi: 10.21037/jgo.2018.11.08

Table 2. Overall survival for all histologic subtypes.

Overall survival TC GCC NEC MANEC Adenocarcinoma
1-year OS 97.4% 95.5% 92.9% 88.6% 86.3%
2-year OS 96.8% 90.5% 88.0% 77.0% 73.5%
3-year OS 95.7% 85.9% 84.8% 73.1% 65.7%
4-year OS 95.7% 82.0% 84.8% 62.2% 57.6%

TC, typical carcinoids; GCC, goblet cell carcinoids; NEC, neuroendocrine carcinomas; MANEC, mixed adenoneuroendocrine carcinomas.